Azenta, Inc. (AZTA)
38.69
+0.82
(+2.17%)
USD |
NASDAQ |
Oct 14, 09:50
Azenta Research and Development Expense (TTM) : 35.73M for June 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 35.73M |
| March 31, 2026 | 34.30M |
| December 31, 2025 | 32.47M |
| September 30, 2025 | 30.39M |
| June 30, 2025 | 29.67M |
| March 31, 2025 | 29.16M |
| December 31, 2024 | 29.30M |
| September 30, 2024 | 29.50M |
| June 30, 2024 | 30.89M |
| March 31, 2024 | 32.95M |
| December 31, 2023 | 33.73M |
| September 30, 2023 | 33.96M |
| June 30, 2023 | 32.67M |
| March 31, 2023 | 30.22M |
| December 31, 2022 | 28.59M |
| September 30, 2022 | 27.54M |
| June 30, 2022 | 26.50M |
| March 31, 2022 | 25.47M |
| December 31, 2021 | 23.81M |
| September 30, 2021 | 22.41M |
| June 30, 2021 | 20.25M |
| March 31, 2021 | 28.36M |
| December 31, 2020 | 38.45M |
| September 30, 2020 | 46.66M |
| June 30, 2020 | 57.11M |
| Date | Value |
|---|---|
| March 31, 2020 | 57.74M |
| December 31, 2019 | 56.52M |
| September 30, 2019 | 56.37M |
| June 30, 2019 | 53.62M |
| March 31, 2019 | 51.43M |
| December 31, 2018 | 48.68M |
| September 30, 2018 | 46.94M |
| June 30, 2018 | 47.65M |
| March 31, 2018 | 47.57M |
| December 31, 2017 | 47.56M |
| September 30, 2017 | 47.00M |
| June 30, 2017 | 46.48M |
| March 31, 2017 | 47.34M |
| December 31, 2016 | 49.11M |
| September 30, 2016 | 51.54M |
| June 30, 2016 | 52.44M |
| March 31, 2016 | 51.75M |
| December 31, 2015 | 49.72M |
| September 30, 2015 | 48.53M |
| June 30, 2015 | 49.41M |
| March 31, 2015 | 49.57M |
| December 31, 2014 | 50.99M |
| September 30, 2014 | 52.09M |
| June 30, 2014 | 51.29M |
| March 31, 2014 | 51.13M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Agilent Technologies, Inc. | 480.00M |
| Bio-Rad Laboratories, Inc. | 260.70M |
| Bruker Corp. | 393.50M |
| Danaher Corp. | 1.615B |
| Harvard Bioscience, Inc. | 9.094M |